TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCsQingyu Liao, Bianqin Guo|Molecular Therapy Oncology|2024Cited by 27
PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathwayYulu Zhang, Bianqin Guo|Molecular Carcinogenesis|2023Cited by 11